Ignite Creation Date:
2025-12-24 @ 6:25 PM
Ignite Modification Date:
2025-12-25 @ 3:55 PM
Study NCT ID:
NCT04398368
Status:
TERMINATED
Last Update Posted:
2023-08-08
First Post:
2020-05-16
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Gemcitabine for the Prevention of Intravesical Recurrence of Urothelial Cancer in Patients With Upper Urinary Tract Urothelial Cancer Undergoing Radical Nephroureterectomy, GEMINI Study
Sponsor:
Mayo Clinic
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-06-05
Start Date Type:
ACTUAL
Primary Completion Date:
2023-02-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-02-02
Completion Date Type:
ACTUAL
First Submit Date:
2020-05-16
First Submit QC Date:
None
Study First Post Date:
2020-05-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-07-17
Results First Submit QC Date:
None
Results First Post Date:
2023-08-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-07-17
Last Update Post Date:
2023-08-08
Last Update Post Date Type:
ACTUAL